Exchange Select Cough Drops

Uses and Indications

This drug is indicated for the temporary relief of cough associated with a cold. It also provides relief from occasional minor irritation and pain due to sore throat or sore mouth.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children aged 2 years and older should dissolve one lozenge slowly in the mouth. This process may be repeated every 2 hours as needed or as directed by a healthcare professional. For children under 2 years of age, it is recommended to consult a doctor before administration.

Contraindications

There are no specific contraindications identified for this product. However, it is essential to adhere to the recommended dosage guidelines, as exceeding the recommended dosage may lead to adverse effects.

Warnings and Precautions

If a patient experiences a severe sore throat that persists for more than two days, or if it is accompanied or followed by fever, headache, rash, swelling, nausea, or vomiting, it is imperative to consult a healthcare professional promptly. These symptoms may indicate a more serious underlying condition that requires immediate attention.

Healthcare professionals should advise patients to discontinue use and seek medical advice if a cough persists for more than one week, recurs, or is accompanied by fever, rash, or a persistent headache. These symptoms may signify a serious condition that necessitates further evaluation.

In cases where a sore mouth does not show improvement within seven days, or if there is ongoing irritation, pain, or redness that persists or worsens, patients should be instructed to stop use and consult a healthcare provider. Monitoring for these symptoms is essential to ensure patient safety and to address any potential complications in a timely manner.

Side Effects

Patients may experience a range of adverse reactions associated with the use of this medication. Serious adverse reactions warrant immediate medical attention, particularly in the case of a severe sore throat that persists for more than two days or is accompanied by fever, headache, rash, swelling, nausea, or vomiting. In such instances, patients are advised to consult a healthcare professional promptly.

Common adverse reactions include a persistent cough that lasts more than one week, recurs, or is accompanied by fever, rash, or a persistent headache. These symptoms may indicate a serious underlying condition, and patients should seek medical advice if they occur. Additionally, if a sore mouth does not show improvement within seven days, or if irritation, pain, or redness persists or worsens, patients should stop use and consult a doctor.

Patients with a history of persistent chronic cough, such as that associated with smoking, asthma, or emphysema, should seek medical advice before using this medication. Furthermore, those experiencing a cough accompanied by excessive phlegm (mucus) are also encouraged to consult a healthcare professional prior to use.

Drug Interactions

No drug interactions have been identified in the available data. Additionally, there are no reported interactions between drugs and laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on the current information.

Packaging & NDC

Below are the non-prescription pack sizes of Exchange Select Cough Drops (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients aged 2 years and older are instructed to dissolve the lozenge slowly in the mouth and may repeat the dosage every 2 hours as needed or as directed by a healthcare professional. For children under 2 years of age, it is recommended to consult a doctor before administration.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Pregnant patients may use this medication as there are no specific warnings or contraindications regarding its use during pregnancy mentioned in the provided drug insert. Additionally, there are no dosage modifications or special precautions required for use in this population. However, healthcare professionals should continue to evaluate the benefits and risks of treatment in pregnant patients, considering individual circumstances and the absence of specific data on fetal outcomes.

Lactation

There are no specific statements regarding the use of this medication in nursing mothers or its effects during lactation. Consequently, healthcare professionals should exercise caution when prescribing this medication to lactating mothers, as the potential risks and benefits have not been clearly established. Further research may be necessary to determine the implications for breastfed infants.

Renal Impairment

There is no information available regarding renal impairment, including dosage adjustments, special monitoring, or safety considerations for patients with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of specific guidance when treating patients with renal impairment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no information available regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted in these patients, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise, as the clinical presentation can vary depending on the substance involved and the individual patient's response. Common symptoms of overdose may include, but are not limited to, altered mental status, cardiovascular instability, and respiratory distress.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs. The use of activated charcoal may be considered if the patient presents within a suitable timeframe and if the ingestion was recent.

Furthermore, specific antidotes or treatments may be indicated based on the substance involved in the overdose. Consultation with a poison control center or a medical toxicologist is recommended to guide the management of the patient effectively.

Overall, vigilance and prompt intervention are critical in managing cases of suspected overdose to mitigate potential complications and ensure patient safety.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question.

Postmarketing Experience

No postmarketing experience details are provided in the insert.

Patient Counseling

Healthcare providers should advise patients to keep this and all medications out of the reach of children to prevent accidental ingestion. Patients should be instructed to stop using the product and consult a doctor if their cough persists for more than one week, tends to recur, or is accompanied by fever, rash, or a persistent headache, as these symptoms may indicate a serious condition. Additionally, if a sore mouth does not improve within seven days, or if irritation, pain, or redness persists or worsens, patients should seek medical advice.

It is important to emphasize that patients should not exceed the recommended dosage while using this product. Healthcare providers should also encourage patients to consult with their doctor prior to use if they have a persistent chronic cough, such as that associated with smoking, asthma, or emphysema, or if their cough is accompanied by excessive phlegm (mucus).

Storage and Handling

The product is supplied in a configuration that includes a primary bag, which must be inspected prior to use. It is essential to ensure that the primary bag seal is intact; do not use the product if the seal has been torn or broken.

Storage conditions require the product to be kept at room temperature. It should be protected from excessive heat and direct sunlight to maintain its integrity and efficacy. Proper handling and storage are crucial to ensure the product remains safe for use.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Exchange Select Cough Drops, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)